Modulation of disease by superantigens

Current Opinion in Immunology

Volumn 10, Issue 4, 1998, Pages 465-470

  Torres, Barbara A ^a   Johnson, Howard M ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STAPHYLOCOCCUS ENTEROTOXIN; SUPERANTIGEN; TAU INTERFERON;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; DISEASE COURSE; HUMAN; IMMUNE RESPONSE; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; MULTIPLE SCLEROSIS; NONHUMAN; PSORIASIS; RELAPSE; REVIEW; RHEUMATOID ARTHRITIS; SENSITIZATION; T LYMPHOCYTE;

EID: 0032146803     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(98)80122-2     Document Type: Article

References (44)

1. bβ region (65-85) is a binding site for the superantigen, staphylococcal enterotoxin A. Biochem Biophys Res Commun. 168:1990;696-701.
2. Dellabona P, Peccoud J, Kappler J, Marrack P, Benoit C, Mathis D. Superantigens interact with MHC class II molecules outside of the antigen binding groove. Cell. 62:1990;1115-1121.
3. Kappler J, Kotzin B, Herron L, Gelfand EW, Bigler RD, Boylston A, Carrel S, Posnett DN, Choi Y, Marrack P. Vβ-specific stimulation of human T cells by staphylococcal toxins. Science. 244:1990;811-813.
4. Soos JM, Schiffenbauer J, Johnson HM. Treatment of PL/J mice with the superantigen, staphylococcal enterotoxin B, prevents development of experimental allergic encephalomyelitis. J Neuroimmunol. 44:1993;39-44.
5. Zamvil SS, Steinman L. The T lymphocyte in experimental allergic encephalomyleitis. Annu Rev Immunol. 8:1990;579-621.
6. Oksenberg J, Panzara M, Begovich AB, Mitchell D, Erlich HA, Murray RS, Shimonkevitz R, Sherritt M, Rothbard J, Bernard CC, Steinman L. Selection for TCR Vβ-D β - J β gene rearrangements with specificity for a myelin basic protein peptide in the brain lesions of multiple sclerosis. Nature. 362:1993;68-70.
7. Soos JM, Hobeika AC, Butfiloski E, Schiffenbauer J, Johnson HM. Accelerated induction of experimental allergic encephalomyelitis in PL/J mice by a non-Vβ8 specific superantigen. Proc Natl Acad Sci USA. 92:1995;6082-6086.
8. Kim C, Siminovitch KA, Ochi A. Reduction of lupus nephritis in MRL/lpr mice by a bacterial superantigen treatment. J Exp Med. 174:1991;1431-1437.
9. Schiffenbauer J, Johnson HM, Butfiloski E, Wegrzyn L, Soo JM. Staphylococcal enterotoxins can re-activate experimental allergic encephalomyelitis. Proc Natl Acad Sci USA. 90:1993;8543-8546.
10. Brocke S, Gaur A, Piercy C, Gautam A, Gijbels K, Fathman CG, Steinman L. Induction of relapsing paralysis in experimental allergic encephalomyelitis by bacterial superantigen. Nature. 365:1993;642-644.
11. Soos JM, Johnson HM. Type I IFN inhibition of superantigen-induced stimulation: Implications for treatment of superantigen associated disease. J Interferon Cytokine Res. 15:1995;39-45.
12. Soos JM, Subramaniam PS, Hobeika AC, Johnson HM. The interferon pregnancy recognition hormone, IFN-tau, blocks both development and superantigen reactivation of experimental allergic encephalomyelitis without associated toxicity. J Immunol. 155:1995;2747-2753.
13. of special interest Soos JM, Mujtaba MG, Subramaniam PS, Streit WJ, Johnson HM. Oral feeding of interferon tau can prevent the acute and chronic relapsing forms of experimental allergic encephalomyelitis. J Neuroimmunol. 75:1997;43-50 The authors show that oral feeding of the novel IFN, IFN-τ, is effective in preventing chronic EAE and in ameliorating chronic EAE, suggesting that oral feeding may be a successful method for IFN-τ administration in the treatment of autoimmune diseases that are exacerbated by superantigens.
14. Anonymous Interferonβ-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo controlled trial. The IFNB Multiple Sclerosis Study Group. Neurology. 43:1993;655-661.
15. of special interest Mujtaba MG, Streit WJ, Johnson HM. IFNτ suppresses both the autoreactive humoral and cellular immune responses and induces remission in mice with chronic experimental allergic encephalomyelitis. Cell Immunol. 1998; The authors show that relapsing/remitting EAE may be modulated to a significant degree by ubiquitous superantigens in the environment. Chronic EAE is ameliorated by interferon (IFN)-τ. IFN-τ inhibits both cellular and humoral autoimmune responses.
16. Paliard X, West SG, Lafferty JA, Clements JR, Kappler JW, Marrack P, Kotzin BL. Evidence for the effects of a superantigen in rheumatoid arthritis. Science. 253:1991;325-329.
17. He X, Goronzy JJ, Weyand CM. The repertoire of rheumatoid factor-producing B cells in normal subjects and patients with rheumatoid arthritis. Arthritis Rheum. 36:1993;1061-1069.
18. Schwab JH, Brown RR, Anderle SK, Schlievert PM. Superantigen can reactivate bacterial wall-induced arthritis. J Immunol. 150:1993;4151-4159.
19. Cole BC, Griffiths MM. Triggering and exacerbation of autoimmune arthritis by the Mycoplasma arthriditis superantigen MAM. Arthritis Rheum. 36:1993;994-1002.
20. of special interest Kumar V, Aziz F, Sercarz E, Miller A. Regulatory T cells specific for the same framework 3 region of the Vbeta8.2 chain are involved in the control of collagen II-induced arthritis and experimental allergic encephalomyelitis. J Exp Med. 185:1997;1725-1733 Collagen-induced arthritis is prevented by pretreatment with the superantigen, staphylococcal enterotoxin B. The authors discuss CIA and other autoimmune disorders in the context of regulatory mechanisms that influence the course of disease.
21. Nagai H, Takaoka Y, Kamada H, Mori H. The model of arthritis induced by superantigen in mice. Life Sci. 55:1994;PL233-PL237.
22. Schlievert PM. Role of superantigens in human disease. J Infect Dis. 167:1993;997-1002.
23. Solem JH, Lassen J. Reiter's disease following Yersinia enterocolitica infection. Scand J Infect Dis. 3:1971;83-85.
24. Valdimarsson H, Baker BS, Jonsdottir I, Powles A, Fry L. Psoriasis: a T cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today. 16:1995;145-149.
25. Leung DY, Travers JB, Giorno R, Norris DA, Skinner R, Aelion J, Kazemi LV, Kim MH, Trumble AE, Kotb M, Schlievert PM. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest. 96:1995;2106-2112.
26. of outstanding interest Valdimarsson H, Sigmundsdottir H, Jonsdottir I. Is psoriasis induced by streptococcal superantigens and maintained by M-protein-specific T cells that cross-react with keratin? Clin Exp Immunol. 107:1997;21-24 This is a thorough update on the role of superantigens in the etiology of psoriasis. The authors discuss a model in which streptococcal superantigens induce specific-Vβ subsets of autoreactive T cells.
27. Watanabe-Ohnishi R, Aelion J, LeGros L, Tomai MA, Sokurenko EV, Newton D, Takahara J, Irino S, Rashed S, Kotb M. Characterization of unique human TCR V beta specificities for a family of streptococcal superantigens represented by rheumatogenic serotypes of M protein. J Immunol. 152:1994;2066-2073.
28. Lafon M, Lafage M, Martinez-Arends A, Ramirez R, Vuiller F, Charron D, Lotteau V, Scott-Algara D. Evidence for a viral superantigen in humans. Nature. 358:1992;507-510.
29. Lafon M, Galleli A. Superantigen related to rabies. Springer Semin Immunopathol. 17:1996;307-318.
30. Sutkowski N, Palkama T, Ciurli C, Sekaly R-P, Thorley-Lawson DA, Huber BT. An Epstein-Barr virus-associated superantigen. J Exp Med. 184:1996;971-980.
31. Schnittman SM, Fauci AS. Human immunodeficiency virus and acquired immunodeficiency syndrome: An update. Adv Intern Med. 39:1994;305-355.
32. Torres BA, Tanabe T, Yamamoto JK, Johnson HM. HIV encodes for its own CD4 T cell superantigen mitogen. Biochem Biophys Res Commun. 225:1996;672-678.
33. Dobrescu D, Ursea B, Pope M, Asch AS, Posnett DN. Enhanced HIV-1 replication in Vβ12 due to human cytomegalovirus in monocytes: evidence for a putative herpesvirus superantigen. Cell. 82:1995;753-763.
34. Held W, Acha-Orbea H, MacDonald HR, Waanders GA. Superantigens and retroviral infection: insights from mouse mammary tumor virus. Immunol Today. 15:1994;184-190.
35. of special interest Dzuris JL, Golovkina TV, Ross SR. Both T and B cells shed infectious mouse mammary tumor virus. J Virol. 71:1997;6044-6048 Data is presented that both B and T cells are infected by MMTV and that both cell types produce infectious virions. Interestingly, the level of T cell infection varies between mouse strains, which correlates with tumor development in those mice. Thus, both B and T cells are potential carriers of MMTV to the mammary gland, the site of transmission of the virus.
36. of outstanding interest Golovkina TV, Dudley JP, Ross SR. Superantigen activity is needed for mouse mammary tumor virus spread within the mammary gland. J Immunol. 1998; Using a MMTV strain having a frameshift in the superantigen gene, the authors show that superantigen, as well as both B and T cells, is required for infection of the mammary gland and, thus, it is essential for transmission of MMTV in milk.
37. + T cells in an MHC-dependent but not MHC-restricted manner. The authors present a model for the role of this superantigen in the onset of type I diabetes.
38. of special interest Tanabe T, Torres BA, Subramaniam PS, Johnson HM. Vβ activation by HIV Nef protein: Detection by a simple amplification procedure. Biochem Biophys Res Commun. 230:1997;509-513 This paper describes a rapid, reproducible method to detect expansion of specific-Vβ subsets of T cells by less potent superantigens.
39. Torres BA, Tanabe T, Johnson HM. Characterization of Nef-induced CD4 T cell proliferation. Biochem Biophys Res Commun. 225:1996;54-61.
40. Bergdoll MS. The staphylococcal enterotoxins - an update. Jelaszewics J. The Staphylococci. 1985;247-266 Gustav Fisher Verlag, New York.
41. Kotzin B, Leung DYM, Kappler J, Marrack P. Superantigens and their potential role in human disease. Adv Immunol. 54:1993;99-166.
42. Lewis HM, Baker BS, Bokth S, Powle AV, Garioch JJ, Valdimarsson H, Fry L. Restricted T cell receptor Vβ gene usage in the skin of patients with guttate and chronic plaque psoriasis. Br J Dermatol. 129:1993;514-520.
43. Ohmen JD, Modlin RL. Evidence for a superantigen in the pathogenesis of human tuberculosis. Springer Semin Immunopathol. 17:1996;375-384.
44. Uchiyama T, Miyushi-Akiyama T, Kato H, Fujimaki W, Imanishi K, Yan X. Superantigenic properties of a novel mitogenic substance produced by Versinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms. J Immunol. 151:1993;4407-4413.